Skip to main content
. 2018 Oct 18;12:371. doi: 10.3389/fncel.2018.00371

Figure 1.

Figure 1

Middle cerebral artery occlusion (MCAO) model was evaluated to be suitable for studying the pharmacology efficacy of Hydroxysafflor yellow A (HSYA). (A) Neurological scores, (B) brain edema, (C) infarct volume, (D) pictures of infarct volume. The values are shown as means ± SEM. Significant difference between sham group vs. MCAO group in neurological scores (sham, n = 8; MCAO, n = 8, ****P < 0.0001), brain edema (sham, n = 2; MCAO, n = 6, **P < 0.01) and infarct volume (sham, n = 2; MCAO, n = 8, ****P < 0.0001).